Anish Potty, MD
Orthopaedic Surgery · Laredo, TXNPI 1902208440
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 26.0% of the total. Reporting peaked in 2019 at $4,892 and has fallen 50.4% since, to $2,427 in 2025.
Across 132 payments — averaging $157.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Dunamis Medical, LLC$4K
- Medinc Of Texas$4K
- Pacira Pharmaceuticals Incorporated$2K
- Medical Device Business Services, Inc.$2K
- Stryker$2K
- plus $2K from 11 others
Across 4 payments — averaging $147.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dunamis Medical, LLC$590
What the payments were for
- Consulting fees$1081%
- Travel & lodging$9,76947%
- Food & beverage$7,23635%
- Education$3,61517%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 51 | $5,397 |
| Dunamis Medical, LLC | 8 | $4,186 |
| Medinc Of Texas | 7 | $3,825 |
| Pacira Pharmaceuticals Incorporated | 10 | $2,061 |
| Medical Device Business Services, Inc. | 11 | $1,563 |
| Stryker | 13 | $1,548 |
| Johnson & Johnson | 14 | $904 |
| Si-bone, Inc. | 4 | $350 |
| Next Science LLC | 3 | $313 |
| Zimmer Biomet | 3 | $313 |
| Arthrosurface Incorporated | 1 | $79 |
| Abbott | 1 | $73 |
| Innovation Technologies Inc | 2 | $40 |
| Prosidyan, Inc | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Ossur Americas, Inc. | 1 | $18 |
| Vericel Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,728 in reported general payments places this provider in the 75th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 74 | $965 |
| Tramadol Hcl | 206 | $689 |
| Methocarbamol | 89 | $584 |
| Gabapentin | 44 | $399 |
| Naproxen | 35 | $212 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 23 | $190 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $112 |
| Meloxicam | 39 | $109 |
| Methylprednisolone | 16 | $104 |
| Ibuprofen | 12 | $90 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Laredo
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.